참고문헌
- Pezzella V, De Martino L, Passariello A, Cosenza L, Terrin G, Berni Canani R. Investigation of chronic diarrhoea in infancy. Early Hum Dev 2013;89:893-7. https://doi.org/10.1016/j.earlhumdev.2013.08.007
- Langley JM, LeBlanc JC, Hanakowski M, Goloubeva O. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol 2002;23:660-4. https://doi.org/10.1086/501990
- Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122:1266-70. https://doi.org/10.1542/peds.2008-0469
- Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile infection in children. JAMA Pediatr 2013;167:567-73. https://doi.org/10.1001/jamapediatrics.2013.441
- Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372:1539-48. https://doi.org/10.1056/NEJMra1403772
- Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012;55:1209-15. https://doi.org/10.1093/cid/cis637
- Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62. https://doi.org/10.1056/NEJM199401273300406
- Schutze GE, Willoughby RE. Clostridium difficile infection in infants and children. Pediatrics 2013;131:196-200. https://doi.org/10.1542/peds.2012-2992
- Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580-4. https://doi.org/10.1097/INF.0b013e31820bfb29
- Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999;45 Suppl 2:II60-8.
- Almeida R, Gerbaba T, Petrof EO. Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol 2016;51:1-10. https://doi.org/10.1007/s00535-015-1099-3
- Rineh A, Kelso MJ, Vatansever F, Tegos GP, Hamblin MR. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther 2014;12:131-50. https://doi.org/10.1586/14787210.2014.866515
- Rousseau C, Levenez F, Fouqueray C, Dore J, Collignon A, Lepage P. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol 2011;49:858-65. https://doi.org/10.1128/JCM.01507-10
- Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007;28:1233-5. https://doi.org/10.1086/520732
- Cohen MB. Clostridium difficile infections: emerging epidemiology and new treatments. J Pediatr Gastroenterol Nutr 2009;48 Suppl 2:S63-5. https://doi.org/10.1097/MPG.0b013e3181a118c6
- Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46 Suppl 1:S19-31. https://doi.org/10.1086/521859
- Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984;28:975-86. https://doi.org/10.1111/j.1348-0421.1984.tb00754.x
- Rolfe RD, Song W. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. J Med Microbiol 1995;42:10-9. https://doi.org/10.1099/00222615-42-1-10
- Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904. https://doi.org/10.1152/physrev.00045.2009
- Ang L, Arboleya S, Lihua G, Chuihui Y, Nan Q, Suarez M, et al. The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination. Sci Rep 2014;4:7417.
- Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007;102:2047-56; quiz 2057. https://doi.org/10.1111/j.1572-0241.2007.01275.x
- Mezoff EA, Cohen MB. Acid suppression and the risk of Clostridium difficile infection. J Pediatr 2013;163:627-30. https://doi.org/10.1016/j.jpeds.2013.04.047
- Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95. https://doi.org/10.1001/jama.294.23.2989
- Evans CT, Johnson S. Prevention of Clostridium difficile infection with probiotics. Clin Infect Dis 2015;60 Suppl 2:S122-8. https://doi.org/10.1093/cid/civ138
- Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012;157:878-88. https://doi.org/10.7326/0003-4819-157-12-201212180-00563
- Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013;382:1249-57. https://doi.org/10.1016/S0140-6736(13)61218-0
- Na JY, Park JM, Lee KS, Kang JO, Oh SH, Kim YJ. Clinical characteristics of symptomatic Clostridium difficile infection in children: conditions as infection risks and whether probiotics is effective. Pediatr Gastroenterol Hepatol Nutr 2014;17:232-8. https://doi.org/10.5223/pghn.2014.17.4.232
- Pant C, Deshpande A, Altaf MA, Minocha A, Sferra TJ. Clostridium difficile infection in children: a comprehensive review. Curr Med Res Opin 2013;29:967-84. https://doi.org/10.1185/03007995.2013.803058
- Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693-703. https://doi.org/10.1056/NEJMoa1012413
- Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, et al. Clinical impact of Clostridium difficile colonization. J Microbiol Immunol Infect 2015;48:241-8. https://doi.org/10.1016/j.jmii.2014.04.011
- Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome--a meta-analysis. Am J Gastroenterol 2006;101:1894-9. https://doi.org/10.1111/j.1572-0241.2006.00654.x
- Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:535-44. https://doi.org/10.1111/j.1365-2036.2007.03399.x
- Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, et al. Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome. Gastroenterology 2016. pii: S0016-5085(16)34926-5. doi: 10.1053/j.gastro.2016.08.003. [Epub ahead of print]
- Perez-Cobas AE, Artacho A, Ott SJ, Moya A, Gosalbes MJ, Latorre A. Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Front Microbiol 2014;5:335.